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Abstract
Cell-to-cell fusion is involved in multiple fundamental biological processes. Prominent examples include osteoclast and
giant cell formation, fertilization and skeletal myogenesis which involve macrophage, sperm-egg and myoblast fusion,
respectively. Indeed, the importance of cell fusion is underscored by the wide range of homeostatic as well as pathologic
processes in which it plays a key role. Therefore, rapid and sensitive systems to trace and measure cell fusion events in
various experimental systems are in demand. Here, we introduce a bipartite cell fusion monitoring system based on a
genetic switch responsive to the site-specific recombinase FLP. To allow flexible deployment in both dividing as well as non-
dividing cell populations, inducer and reporter modules were incorporated in lentivirus vector particles. Moreover, the
recombinase-inducible transcription units were designed in such a way as to minimize basal activity and chromosomal
position effects in the ‘‘off’’ and ‘‘on’’ states, respectively. The lentivirus vector-based conditional gene expression assay was
validated in primary human mesenchymal stem cells and in a differentiation model based on muscle progenitor cells from a
Duchenne muscular dystrophy patient using reporter genes compatible with live- and single-cell imaging and with whole
population measurements. Using the skeletal muscle cell differentiation model, we showed that the new assay displays low
background activity, a 2-log dynamic range, high sensitivity and is amenable to the investigation of cell fusion kinetics. The
utility of the bipartite cell fusion monitoring system was underscored by a study on the impact of drug- and RNAi-mediated
p38 MAPK inhibition on human myocyte differentiation. Finally, building on the capacity of lentivirus vectors to readily
generate transgenic animals the present FLP-inducible system should be adaptable, alone or together with Cre/loxP-based
assays, to cell lineage tracing and conditional gene manipulation studies in vivo.
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Introduction
Diverse biological phenomena involve fusion between either the
same or different cell types (i.e. homotypic and heterotypic cell
fusion, respectively). Notable examples include osteoclast and giant
cell formation (macrophage fusion), fertilization (sperm-egg
fusion), syncytiotrophoblast formation (cytotrophoblast fusion)
and skeletal muscle development and regeneration (myoblast
fusion). In addition, recent studies indicate that in parallel to these
canonical cell fusion processes there are also those involving non-
canonical or atypical cell fusion events. For example, it has been
advanced that cancers may progress through heterotypic cell
fusion between tumor cells and cells with tissue-infiltrating
capacity such as macrophages [1,2]. Another example is the
occurrence of low-level heterotypic cell fusion between stem or
progenitor cells from one tissue and parenchymal cells from
another tissue especially under conditions disrupting the homeo-
stasis of the recipient organ. The latter phenomenon stirred up the
stem cell field by providing an alternative explanation to some of
the early observations on stem cell plasticity whereby cells, in some
cases, purportedly transdifferentiated, i.e. acquired a phenotype
different from the cells of their tissue of origin [3]. In addition, cell-
to-cell fusion is also a feature evolved by syncytium-forming viruses
(e.g. human immunodeficiency virus [HIV] and measles) to
facilitate spreading through their hosts [4,5]. Of note, syncytium
formation ‘‘as-a-means-to-spread’’ has been proposed as a process
that could be exploited to increase the potency of oncolytic virus-
based vectors [6–8]. Given its relevance in biology, flexible and
sensitive assays to detect and measure cell-to-cell fusion are
expected to have a broad applicability.
Cell fusion activity is often expressed in terms of the ‘‘fusion
index’’. The ‘‘fusion index’’ is obtained by estimating the
frequency of nuclei associated with syncytia in relation to the
total number of nuclei. Alternatively, putative fusion partners can
be marked with different fluorescent proteins or dyes that produce
a distinctive combinatorial spectral signature after fusion between
the differently labeled cells takes place [9]. Also, species-specific
antibodies as well as species- or gender-specific chromosome
probes can be applied to detect fusion events between cells of
different organisms or genders. These methods, however, are
based on microscopic inspection and cell counting by different
researchers and, as a consequence, they are fastidious, time-
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high-throughput capabilities, accuracy and reproducibility. Addi-
tionally, ‘‘fusion index’’ estimations cannot discriminate bona fide
cell fusion events from aborted cytokinesis.
To overcome these limitations more quantitative and repro-
ducible cell fusion assays have been developed (for a review see
[10]). Because the most direct method of demonstrating cell fusion
is to ascertain mixing of cellular constituents of the interacting
partners, these assays have in common the measurement of a new
signal output only after such mixing occurs. The majority of
quantitative cell fusion assays are based either on biochemical
complementation or on transcription activation principles. The
former rely on assembly of tetrameric complexes consisting of two
Escherichia coli b-galactosidase subunits that per se are non-
functional due to the deletion of crucial protein domains [11],
whereas the latter depend on bacteriophage T7 RNA polymerase-
or bacteriophage Cre recombinase-responsive reporter genes [10].
The Cre recombinase-based systems possess a characteristic
arrangement of genetic elements (see below) and allow the
detection of sporadic cell fusion events in vivo [12]. Of note,
normally low Cre concentrations suffice to induce target DNA
rearrangement with subsequent signal amplification being relayed
via reporter gene transcriptional activity. In contrast, albeit
potentially faster in reporting cell fusion events, the b-galactosidase
complementation method require the component protein subunits
to be present in high and, ideally, equimolar amounts to facilitate
the assembly of catalytically active enzyme complexes.
This report describes the development and testing of a novel
two-component transcription activation-dependent cell fusion
assay based on the introduction into separate test cell populations
of recombinase-encoding and recombinase-responsive transcrip-
tion units. The recombinase-encoding expression unit directs the
synthesis of FLPe, an enhanced version of the Saccharomyces cerevisiae
site-specific recombinase FLP [13], whereas the recombinase-
responsive transcription module contains a direct repeat of FLP
recognition target (FRT) sites embedded within a unique
arrangement of transcription elements that allows the formation
of functional transgenes solely upon the generation of circular
episomes (see below). This FLPe-responsive molecular switch,
which differs from those usually applied in recombinase-activa-
table transgenes, was chosen to minimize reporter gene basal
activity in the ‘‘off’’ state and to avoid chromosomal position
effects, including transcriptional interference, on reporter gene
expression in the ‘‘on’’ state. Importantly, to allow rapid and
flexible deployment in dividing and non-dividing cells as well as in
cells displaying a limited replicative life span (e.g. most primary
cells), both components of the assay system were incorporated into
lentivirus vector particles. This new conditional gene expression
system was validated in an ex vivo differentiation model based on
myoblasts from a Duchenne muscular dystrophy (DMD) patient
[14] using reporter genes amenable to live- and single-cell imaging
and to whole-population measurements. Finally, by deploying the
bipartite cell fusion monitoring system together with short-hairpin
RNAs (shRNAs) and the specific p38a/b inhibitor SB 203580 we
showed the involvement of the p38 mitogen-activated protein
kinase (MAPK) pathway in human myotube formation.
Results and Discussion
Experimental rationale and design
Chromosomal position effects imparted on transgenic DNA by
flanking genomic sequences potentially complicate reliable quan-
tification of recombinase-dependent transgene expression. This
pitfall may be overcome by using clonal derivatives of the test cells
or by targeted insertion of the recombinase-activatable transcrip-
tion unit into specific chromosomal loci. However, both these
approaches rely on the establishment and screening of single-cell
clones which makes them laborious and time-consuming.
Moreover, recombinant DNA transfer as well as selection and
expansion of clones are not easily applicable to cells with a limited
replicative life span like most primary mammalian cells. Further-
more, working with single-cell clones may yield biased results due
to the possible existence of phenotypic heterogeneity in the test cell
population.
Besides their prominent role in gene therapy research [15],
lentivirus vectors have become widely used gene transfer tools due
to their straightforward production and capacity to stably transduce
both dividing and non-dividing cells with high efficiency. The
versatility of lentivirus vector technology is further underscored by
its successful deployment in establishing transgenic rodent lines
[16,17]. Lentivirus vectors achieve permanent genetic modification
of transduced cells by integrating DNA copies of their genomes into
the host cell’s chromosomal DNA. Integration events, however, are
not strictly random since the lentiviral pre-integration complexes
preferentially target actively transcribed open reading frames
(ORFs) [18,19]. As a result, individual DNA integrants become
subjected to different chromatin environments and associated
regulatory cis-acting elements leading to positional effects on
transgene expression (Fig. 1A). In the context of a recombinase-
dependent conditional gene expression system with a conventional
organization of genetic elements these chromatin positional effects
may include in cis (depicted) and in trans transcriptional interference
on reporter gene expression (Fig. 1A). To minimize these effects we
designed a lentivirus vector encoding a recombinase-dependent
gene switch module with an arrangement of its genetic elements as
illustrated in Fig. 1B. Of note, this lentivirus vector-based
conditional gene expression system contains the unidirectional
murine metallothionein gene polyadenylation signal (pA) previously
shown to block cryptic transcription of a promoterless ORF located
downstream of it [20]. This element, as well as the reporter ORF
and the rabbit b-globin pA associated with it, are oriented in the
opposite direction to that of the lentivirus vector 59 long terminal
repeat (LTR)-driven transcription to prevent interference with the
generationof full-length vector genomes during particle production.
FLPe-mediated site-specific DNA recombination and ensuing
reporter gene activation is concomitant with a transition of the
expression unit from a chromosomal to an episomal context. This
topological change should eliminate possible negative or positive
effects of chromosomal cis-acting regulatory elements on reporter
gene expression (Fig. 1B). Putative DNA integrant-specific reporter
activity in the ‘‘on’’ state due to epigenetic modifications acquired
by the transgenic sequences following their host cell genome
insertion is expected to be avoided neither by the traditional nor by
the new gene switch design.
Generation and testing of lentivirus vectors bearing
recombinase-responsive reporter genes whose activation
is dependent on episome formation
We started by testing whether lentivirus vector particles
encoding a FLP-dependent gene switch with the structural
organization depicted in Fig. 1B could be generated and,
following indicator cell transduction, express the reporter gene
in a recombinase-dependent manner. To this end, LV.GS.DsRed
particles produced by using the lentivirus vector shuttle plasmid
pLV.pA+.GS.DsRed (Fig. 2) were added onto myoblasts derived
from a satellite cell of a DMD patient [14] at 0, 3, 9 and 15
transducing units (TU)/cell. The pLV.pA+.GS.DsRed construct
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of Discosoma sp. designated DsRed.T4-N1 [21].
Next, these cells were either mock-infected or incubated with a
single dose of the FLPe-encoding lentivirus vector LV.FLPe or of
the FLPe-encoding high-capacity adenovirus vector HD.FLPe.F50
[22] (hereinafter referred to as HD.FLPe). Three days post-infection
direct fluorescence microscopy revealed that synthesis of RFP was
dependent on the presence of FLPe and that more red fluorescent
myoblasts were observed in cultures initially exposedto higherdoses
ofLV.GS.DsRed(Fig.3A).Inanotherexperiment,parallelcultures
of DMD myoblasts transduced with LV.GS.DsRed at 0, 3, 9 and
15 TU/cell were exposedto increasing amounts of HD.FLPe(i.e. 0,
10, 20, 30 and 40 gene switch-activating units [GSAU]/cell) or
LV.FLPe (i.e. 0, 10, 20, 30 TU/cell). Flow cytometric analyses
performed at 3 days after infection confirmed FLPe-mediated
transgene activation and an LV.GS.DsRed dose-dependent in-
crease in the frequency of RFP-positive cells (Fig. 3B). Dot plots
corresponding to the flow cytometric analyses of DMD myoblasts
exposed to or not exposed to HD.FLPe, are depicted in Fig. 3C
(right and left panel, respectively). Importantly, in the absence of
FLPe, the frequency of RFP-positive cells in myoblast cultures
transduced with increasing amounts of LV.GS.DsRed remained
below 1% (range: 0.28–0.81%).
On the basis of the results described above, we constructed
pLV.pA+.GS.Luc to allow quantification of cell fusion activity in
whole cell populations. This lentivirus vector shuttle plasmid
contains the luciferase gene from Photinus pyralis (Fig. 2) whose
product permits the detection of gene expression within a very
wide linear range by using simple bioluminescence assays. These
assays measure the visible light emitted during the enzymatic
conversion of luciferin to oxyluciferin. Lentivirus vector particles
were generated by using the shuttle plasmid pLV.pA+.GS.Luc.
The functionality of the LV.GS.Luc particles generated with the
aid of pLV.pA+.GS.Luc was evaluated by transducing primary
human mesenchymal stem cells (hMSCs) [9] and human
myoblasts [14] at 30 TU/cell. Mock-transduced hMSCs and
mock-transduced human myoblasts served as negative controls.
Subsequently, cultures of these two different indicator cell types
were exposed to the FLPe-encoding adenovirus vector HD.FLPe
at 3, 15 and 75 GSAU/cell [22]. Data shown in Figs. 3D and
Figure 1. Structure and modus operandi of recombinase-responsive lentivirus vector-based gene switch modules with the
conventional (A) or the episomal design (B). SIN LTR, SIN hybrid long terminal repeat composed of HIV-1 and RSV sequences; y, HIV-1
packaging signal; RTS, recombinase target site; pA, polyadenylation signal; dashed magenta lines, chromosomal DNA; magenta and green broken
arrows, endogenous and exogenous promoter elements, respectively. See the main text section ‘‘Experimental rationale and design’’ for a detailed
explanation of the figure.
doi:10.1371/journal.pone.0010954.g001
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e10954Figure 2. Diagram of the lentivirus vector shuttle plasmids pLV.pA+.GS.DsRed and pLV.pA+.GS.Luc. Grey box with broken arrow, 59
hybrid long terminal repeat (LTR) containing Rous sarcoma virus and HIV-1 sequences; Grey box without broken arrow, 39 SIN LTR; y, HIV-1 packaging
signal; Cyan arrowheads, FLP recognition target (FRT) sites; orange box with broken arrow, human glyceraldehyde-3-phosphate dehydrogenase
(hGAPDH) gene promoter; Large and small green boxes, rabbit b-globin and murine metallothionine gene pAs (rBGpA and mMTpA, respectively); red
box, DsRed.T4-N1 ORF from Discosoma sp. (DsRed); yellow box, luciferase ORF from Photinus pyralis (PpLuc). All genetic elements are drawn to scale.
doi:10.1371/journal.pone.0010954.g002
Figure 3. Functional testing of the lentivirus vectors LV.GS.DsRed and LV.GS.Luc. (A) Direct fluorescence microscopy of human myoblasts
not exposed (mock) or exposed to 3 different doses of LV.GS.DsRed (i.e. 3, 9 and 15 TU/cell) in the absence (no FLPe) or in the presence of FLPe
(LV.FLPe or HD.FLPe). (B) Flow cytometric analysis of human myoblasts transduced with 3 different dosages of LV.GS.DsRed (i.e. 3, 9 and 15 TU/cell)
and subsequently exposed to increasing amounts of FLPe-encoding viral vectors (i.e. LV.FLPe [open bars] and HD.FLPe [solid bars]) or not.
Experimental conditions not tested are marked by an asterisk (*). (C) Dot plot representation of DsRed.T4-N1 expression in human myoblasts stably
transduced with LV.DsRed (myoblasts
GS.DsRed) in the absence (-FLPe) or presence (+FLPe) of HD.FLPe. (D and E) Luminometric analysis of luciferase
activity in lysates derived from hMSCs or myoblasts mock-treated (D and E; hMSCs
mock and myoblasts
mock, respectively) and from hMSCs or
myoblasts LV.GS.Luc-transduced (D and E; hMSCs
GS.Luc and myoblasts
GS.Luc, respectively) that were or were not exposed to different amounts of
HD.FLPe particles. Graph bars shows mean 6 standard error of the mean (n=3). RLU, relative light units.
doi:10.1371/journal.pone.0010954.g003
Vector-Based Cell Fusion Assay
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e109543E clearly demonstrate that robust luciferase gene expression in
both hMSCs (Fig. 3D) and human myoblasts (Fig. 3E)i s
dependent on the presence of FLPe. For each of the HD.FLPe
doses applied, the fold increase in luciferase activity in comparison
to cells transduced exclusively with LV.GS.Luc, was similar for
both cell types (i.e. 50, 80 and 102 for hMSCs versus 68, 84 and 91
for myoblasts at HD.FLPe doses of 3, 15 and 75 GSAU/cell,
respectively).
Taken together these data indicate that (i) the specific
arrangement of genetic elements in the FLP-responsive reporter
gene-containing shuttle plasmids is compatible with the synthesis
and packaging of lentivirus vector genomic RNA and (ii) host cell
promoter-driven reporter gene expression is contained as evident
from the low basal expression levels measured following proviral
vector DNA integration into the genome of the indicator cells.
Quantification of cell fusion in ex vivo cultures of human
muscle progenitor cells
To investigate the suitability of the present lentivirus vector-
based inducible reporter gene system to detect and quantify cell
fusion events we exploited an ex vivo cellular differentiation model
based on human myoblasts. In this system, activation of the
terminal myogenic differentiation program is simply accomplished
by withdrawing mitogens from the culture medium. This triggers
the homotypic fusion of the mononucleated muscle progenitor
cells resulting in a time-dependent accumulation of nuclei in
syncytial structures called myotubes.
FLPe-encoding human myoblasts were generated through
transduction with the lentivirus vector LV.FLPe.PurR followed by
selection of genetically modified cells using puromycin. Five days
after the initiation of puromycin-mediated selection, an LV.FLPe.
PurR dose-dependent increase in cell survival could be discerned
(Fig. 4A). Repeated passaging of LV.FLPe.PurR-transduced
human myoblasts in the presence of puromycin revealed no
apparent differences in the growth rate between cell cultures
exposed to the different amounts of FLPe-encoding vector tested
(not shown). Thus, we selected myoblasts transduced with the
highest LV.FLPe.PurR dose (hereinafter referred to as myo-
blasts
FLPe) to carry out the subsequent experiments. In parallel,
reporter gene-modified test cells (hereinafter referred to as
myoblasts
GS.Luc) were generated by transducing human myoblasts
with LV.GS.Luc at a multiplicity of infection of 30 TU/cell.
To determine whether the lentivirus vector-based inducible
reporter gene system displays (i) low basal activity in the presence
of FLPe-positive cells and (ii) high fusion-dependent induction
factors, we mixed myoblasts
FLPe with myoblasts
GS.Luc at different
ratios (i.e. 90:10, 75:25, 50:50, 25:75 and 10:90) (Fig. 4B).
Cultures consisting exclusively of myoblasts
FLPe (i.e. 100:0) or of
myoblasts
GS.Luc (i.e. 0:100) served as negative controls (Fig. 4B).
The extent of myogenic differentiation observed in each of the
myoblast cultures after mitogen withdrawal was similar (not
shown). Bioluminescence measurements immediately prior to as
well as after the completion of the myoblast-myotube differenti-
ation schedule clearly revealed a differentiation/fusion-dependent
increase in luciferase activity. Indeed, reporter gene expression
levels more than 2 orders of magnitude above those in non-
differentiated cells were consistently measured exclusively in co-
cultures of myoblasts
FLPe and myoblasts
GS.Luc (Fig. 4B).
Analysis of cell fusion kinetics in ex vivo cultures of
human muscle progenitor cells
As previously mentioned, upon induction of myogenic differ-
entiation a gradual accumulation of myotubes of growing size and
with an increasing number of nuclei can be observed in cultures of
myoblasts as a consequence of ongoing cell fusion. Conversely,
parallel cultures kept under normal growth medium are mostly
devoid of myotubes. We asked whether this myogenic differenti-
ation phenomenon could be followed as a function of time by
deploying the lentivirus vector-based conditional gene expression
system presented above (Fig. 5). To this end, myoblasts
FLPe were
mixed with myoblasts
GS.Luc at a 1:1 ratio using two different total
amounts of cells (i.e. 10
5 and 2610
5). The resulting co-cultures
were subsequently either kept in growth medium or were exposed
to differentiation medium for different periods of time (Fig. 5A,
upper and lower panels, respectively). Luminometric analyses of
lysates from cells maintained in differentiation medium revealed a
time-dependent increase in luciferase activity, which correlatedwith
the time-dependent rise in the frequency and size of myotubes. In
addition, consistent with the previous findings (Fig. 4B), parallel
co-cultures of myoblasts
FLPe and myoblasts
GS.Luc maintained in
regular growth medium did not show a time-dependent rise in
luciferase expression despite the increase in cell numbers due to
mitosis (Fig. 5B, solid bars in right panels). These data suggest
that the newly developed lentivirus vector-based conditional gene
expression system can be deployed not only to quantify muscle
cell differentiation activity but should also be useful to investigate
Figure 4. Fusion-dependent reporter gene activation in an ex
vivo human skeletal muscle cell differentiation system. (A)
Establishment of FLPe-positive human myoblast cultures. Phase-
contrast microcopy of human myoblasts initially incubated with 0, 30,
300 and 900 ml of cleared culture supernatant from LV.FLPe.PurR-
producing 293T cells. Micrographs were acquired 7 days posttransduc-
tion and 5 days after the addition of puromycin to a final concentration
of 1.0 mg/ml. (B) Luminometric analysis of cell lysates derived from co-
cultures of human myoblasts stably transduced with LV.FLPe.PurR or
with LV.GS.Luc (myoblasts
FLPe and myoblasts
GS.Luc, respectively). The
two types of human myoblast populations were mixed at the indicated
ratios and luciferase activity was measured before (B) and after (A)
myogenic differentiation. Bars represent mean 6 standard error of the
mean (n=3). RLU, relative light units.
doi:10.1371/journal.pone.0010954.g004
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Determining the sensitivity of the lentivirus vector-based
inducible reporter gene assay to detect cell fusion in ex
vivo cultures of differentiating human myoblasts
Earlier data showed that transgene expression in co-cultures of
myoblasts
GS.Luc and myoblasts
FLPe increased with increasing
fractions of myoblasts
GS.Luc (Fig. 4B) suggesting that the number
of gene switch modules available for FLP-mediated recombination
was limiting. This is consistent with the idea that relatively few
molecules of recombinases such as Cre or FLP suffice to bring
about site-specific recombination and that, necessarily, the more
luciferase copies are present in the bipartite gene expression system
the higher the likelihood for reporter protein synthesis to occur.
Thus, to determine the minimum percentage of myoblasts
FLPe
that still leads to a measurable fusion-dependent signal output, we
set up an experiment in which the frequency of myoblasts
FLPe was
titrated on a constant total amount of 2610
5 myoblasts. The
fraction of myoblasts
FLPe present in co-cultures of myoblasts
FLPe
and myoblasts
GS.Luc was varied in a series by a factor of 3. Of note,
no obvious differences in the frequency and size of myotubes were
observed between the co-cultures containing different ratios of
myoblasts
FLPe and myoblasts
GS.Luc (Fig. 6A). Chemiluminescence
measurements performed after the regular differentiation period
showed that a frequency of myoblasts
FLPe as low as 0.04% could
still give rise to a luciferase signal above that measured in cultures
containing exclusively myoblasts
GS.Luc (i.e. background [grey bar])
(Fig. 6B). These results bode well for the deployment of the
current lentivirus vector-based conditional gene expression system
in instances in which fusion events are rare. Even so, ways by
which to optimize the current set up can be envisioned. These
include (i) flanking of the gene switch module by insulator
sequences to block host cell enhancer activity on reporter gene
expression during the proviral vector stage, (ii) placing transgene
expression under the control of a promoter stronger than that of
the human glyceraldehyde-3-phosphate dehydrogenase gene and (iii)
Figure 5. Time-dependent reporter gene activation in an ex vivo human skeletal muscle cell differentiation system. (A) Phase contrast
microscopy of co-cultures containing myoblasts
FLPe and myoblasts
GS.Luc at a 1:1 ratio after incubation for 2, 3, 4 or 5 days in growth medium (upper
panels) or in differentiation medium (lower panels). (B) Luminometric analysis of cell lysates prepared at 12-hour intervals from co-cultures initiated
with 5610
4 myoblasts
FLPe and with 5610
4 myoblasts
GS.Luc (upper panels) or with 10
5 myoblasts
FLPe and with 10
5 myoblasts
GS.Luc (lower panels). The
cells were either maintained in growth medium (solid bars) or in differentiation medium (open bars). The relative light units (RLU) are plotted on
linear (left panels) and logarithmic (right panels) scales. Bars correspond to mean 6 standard error of the mean (n=3).
doi:10.1371/journal.pone.0010954.g005
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sequences by those of reporter proteins with higher specific activity
like DsRed-Express2 [23] and Gaussia princeps luciferase [24]. Of
note, the latter reporter protein in its secreted [24] or membrane-
anchored [25] form should permit adjustment to novel exper-
imental read-outs with the added advantage of displaying a higher
sensitivity than other commonly used luciferases. Finally, analysis
of cell fusion kinetics may profit from the deployment of
destabilized versions of luciferase or other reporter proteins.
Pharmacological and genetic interference with the p38
MAPK pathway and its impact on the human myoblast
fusion process
Various studies, mostly in murine and rat cells, have shown that
the p38 MAPK pathway plays a pivotal role in skeletal myogenesis
through, amongst others, phosphorylation-dependent activation of
myogenic transcription factors and its ability to induce chromatin
remodeling of skeletal muscle-specific gene promoters. A recent
study deploying neonatal myoblasts derived from mice in which
the p38a, p38b, p38c and p38d genes were individually knocked
out pinpointed p38a as the most crucial p38 MAPK in this muscle
cell differentiation system [26]. In fact, murine muscle progenitor
cells lacking p38b or p38d did not present any apparent defect in
their fusion ability whereas those without p38c displayed a delayed
fusion phenotype [26].
To determine whether the bipartite conditional gene expression
system could be used to establish the involvement of the p38 MAPK
pathway during the differentiation of myocytes from human adults,
we deployed the p38a/b-specific inhibitor SB 203580 or shRNAs
targeting p38a transcripts. Co-cultures consisting of myoblasts
FLPe
and myoblasts
GS.Luc kept in regular differentiation medium or in
differentiation medium supplemented with either SB 203580 (0.1,
0.5 and 2.5 mM) or vehicle only, revealed a clear drug-dependent
reduction in myoblast fusion activity as determined by chemilumi-
nescence measurements (Fig. 7A). Subsequently, by using lentivirus
vector-mediated gene transfer and puromycin selection, we screened
on the background of myoblasts and myoblasts
GS.Luc cells,
polyclonal lines encoding shRNAs designed for post-transcriptional
down-regulation of p38a (4 shRNAs), eGFP (1 shRNA) or murine
hypoxia inducible factor 1a (hif1a)( 1s h R N A )e x p r e s s i o n .S c r e e n i n go f
t h er e l a t i v ea m o u n t so fp 3 8 a protein synthesized in parental
myoblasts and myoblasts
GS.Luc as well as in the various shRNA-
encoding polyclonal cell populations derived from them was carried
out by Western blot analysis. Results depicted in Fig. 7B show that
myoblast and myoblast
GS.Luc lines encoding shRNAs sh.p38a.33
and sh.p38a.36 displayed consistent p38a knock-down. To measure
the impact of p38a knock-down on human myocyte fusion, the
experimental set-up outlined in Fig. 7C was followed. Cultures of
parental myoblasts, myoblasts
sh.hif1a,m y o b l a s t s
sh.p38a.33 and myo-
blasts
sh.p38a.36 were divided and transduced either with LV.FLPe or
with LV.GS.Luc. After sub-culturing, the resulting FLPe-encoding
cell populations were mixed at a 1:1 ratio with their respective
GS.Luc-containing counterparts (i.e. myoblasts
sh.p38a.36FLPe were
Figure 6. Probing the sensitivity of the lentivirus vector-based
conditional gene expression assay to detect myoblast fusion.
(A) Phase contrast microscopic images of cultures started with a total
number of 2610
5 myoblasts. The pictures were taken after a 5-day
incubation in differentiation medium. These cultures consisted exclu-
sively of myoblasts
GS.Luc (bar labeled 0:100) or of myoblasts
FLPe (bar
labeled 100:0) or, contained mostly myoblasts
GS.Luc (90–99.96%) spiked
with different amounts of myoblasts
FLPe (i.e. 0.04, 0.12, 0.37, 1.1, 3.3 and
10%). (B) Luciferase activity in cultures initiated with a total number of
2610
5 myoblasts and exposed for 5 days to differentiation medium.
The cultures were composed exclusively of myoblasts
GS.Luc (grey bar) or
of myoblasts
FLPe (white bar) or contained myoblasts
GS.Luc (90–99.96%)
together with low proportions of myoblasts
FLPe (i.e. 0.04, 0.12, 0.37, 1.1,
3.3 and 10%). Cumulative data are expressed as means 6 standard error
of the mean (n=3). P values resulting from the comparison of relevant
experimental groups were determined using an unpaired one-tailed
Student’s t-test. P values ,0.05 were considered significant. RLU,
relative light units.
doi:10.1371/journal.pone.0010954.g006
Vector-Based Cell Fusion Assay
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e10954mixed with myoblasts
sh.p38a.36GS.Luc and so forth). Luminometry-
based cell-to-cell fusion measurements following the exposure of the
various co-cultures to differentiation medium for 4 days showed that
specific down-regulation of p38a expression in human muscle
progenitor cells results in impaired cell fusion (Fig. 7D). These
results together with those presented in Fig. 7A indicate that the
p38 MAPK pathway is involved in terminal differentiation of
human myoblasts in vitro.
In summary, we introduce herein a novel cell fusion assay based
on the activation of a reporter gene by recombinase-dependent
episome formation. We showed that, following lentivirus vector-
mediated gene transfer, the reporter units display low basal activity
and a strict dependency on the FLP recombinase for their
activation. These features combined with the ability of lentivirus
vectors to swiftly generate transgenic mammals [16,17] might
render the present FLP-responsive system useful to investigate cell
fusion in vivo and, alone or together with Cre/loxP-based assays,
assist incell-lineage and conditional gene expressionstudies.Finally,
in this post-genomic era, the challenge is to go from primary
sequence data to phenotypic associations that are underpinned by
functionalread-outs.Keytothisongoing endeavoristhe continuous
development of robust high-throughput cell-based assays to link
genotypes to specific phenotypes. Related to this, we expect the
current gene switch system combined with high-throughput
screening of chemical, small interfering/short hairpin RNA and
cDNA libraries [27–30] to serve as a powerful methodology to
identify molecules and pathways involved in the ill-understood
process of mammalian muscle cell fusion. As an initial proof-of-
Figure 7. Pharmacological and genetic inhibition of the p38 MAPK pathway and its impact on human myotube formation in vitro.
(A) Luminometric analysis of cell lysates generated from co-cultures initiated with 10
5 myoblast
FLPe and 10
5 myoblast
GS.Luc cells and exposed for 3
days to differentiation medium (white bar), to differentiation medium supplemented with 0.1, 0.5 and 2.5 mM SB 203580 (black bars) or to
differentiation medium containing a final concentration of vehicle equivalent to that applied to co-cultures incubated with 2.5 mM SB 203580 (grey
bar). Cumulative data are presented as means 6 standard deviations (n=3). RLU, relative light units. (B) Western blot analysis of p38a levels in
protein lysates of parental myoblasts and myoblasts
GS.Luc (mock) and of myoblasts and myoblasts
GS.Luc stably transduced with shRNA modules
designed to down-regulate expression of eGFP (sh.eGFP), hif1a (sh.hif1a) and human p38a (sh.p38a.35, sh.p38a.33, sh.p38a.36 and sh.p38a.34). The a-
and b-tubulins served as loading control. (C) Diagram outlining the experimental set-up applied to investigate the impact of post-transcriptional
down-regulation of p38a expression on human myocyte fusion (see text for details). (D) Quantification through chemiluminescence of myoblast
fusion activity in co-cultures consisting of a 1:1 mixture of FLPe- and GS.Luc-encoding myoblasts either not transduced (none) or stably transduced
with shRNAs sh.p38a.33, sh.p38a.36 or sh.hif1a. Data were derived from a minimum of 3 and a maximum of 6 different experiments and are
presented as means 6 standard error of the mean. RLU, relative light units.
doi:10.1371/journal.pone.0010954.g007
Vector-Based Cell Fusion Assay
PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e10954principle we used the conditional gene expression assay presented
herein to demonstrate by two different approaches the involvement
of the p38 MAPK pathway during terminal differentiation of
human myocytes in vitro.
Materials and Methods
Recombinant DNA
DNA constructions were carried out by using established
procedures [31] or following the instructions provided with
specific reagents. In brief, construct pLV.CMV.hMyoD.eGFP
[32] (GenBank accession number: EU048697) was digested with
Bsu15I and Bsp1407I (both from Fermentas). The 6.3-kb DNA
segment containing the plasmid backbone was extracted from gel
and its 39 recessed ends were filled in with Klenow polymerase
(Fermentas). In parallel, pGS.pA+.DsRed [20] was digested with
SmaI, HindIII and SspI. The resulting 2.4-kb fragment was
extracted from gel and treated with Klenow polymerase. The 6.3-
kb and 2.4-kb DNA fragments were ligated to each other giving
rise to construct pLV.pA+.GS.DsRed. To construct pLV.pA+
.GS.Luc, pLV.pA+.DsRed and pGL3.Basic (Promega) were
digested with BcuI plus MluI and HindIII plus XbaI, respectively.
Next, the 8.0-kb pLV.pA+.GS.DsRed fragment without the
DsRed.T4-N1 ORF and the luciferase-coding DNA segment from
pGL3.Basic were extracted from gel, blunt-ended with Klenow
polymerase and ligated to each other, yielding pLV.pA+.GS.Luc.
All ligation mixtures were introduced into the GeneHogs strain
of Escherichia coli (Invitrogen) and large-scale plasmid purifications
were performed using JETSTAR 2.0 Plasmid Maxiprep kits
(Genomed) according to the manufacturer’s instructions. The
nucleotide sequences of pLV.pA+.GS.DsRed and pLV.pA+
.GS.Luc can be retrieved by using GenBank accession numbers
GU253312 and GU253313, respectively. In addition, the
annotated sequences corresponding to the FLPe-encoding lentivi-
rus vector shuttle plasmids pLV.FLPe and pLV.FLPe.PurR can
be accessed via GenBank accession codes GU253315 and
GU253314, respectively.
Cells
The culture conditions for the hMSCs [9] as well as the culture
and differentiation conditions for the human myoblasts [14] have
been described previously [9,14,33].
Viral vectors
The production and titration of the FLPe-encoding high-capacity
adenovirusvectorHD.FLPehavebeendetailedelsewhere[22].The
vesicular stomatitis virus G protein-pseudotyped self-inactivating
(SIN) HIV type 1 (HIV-1)-based vectors LV.FLPe, LV.FLPe.PurR,
LV.GS.DsRed and LV.GS.Luc were generated in 293T cells with
the aid of the packaging plasmids psPAX2 (Addgene) and pLP/
VSVG (Invitrogen) as specified before [32]. To concentrate and
purify lentivirus vector particles, producer cell supernatants were
layered onto 5-ml cushions of 20% (wt/vol) sucrose (Merck) in
phosphate-buffered saline (PBS) and centrifuged at 15,000 rotations
per minute (rpm) for 2 hours at 10uC in an SW28 rotor (Beckman
Coulter). Prior to ultracentifugation, producer cell supernatants
were subjected to filtration through 0.45-mm pore-sized cellulose
acetate filters (Pall). The VSV-G-pseudotyped HIV-1-based vectors
LV.sh.eGFP, LV.sh.hif1a, LV.sh.p38a.33, LV.sh.p38a.34,
LV.sh.p38a.35 and LV.sh.p38a.36 were generated in 293T cells
by using pLKO.1-puro clones SHC005, TRCN0000054448,
TCRN0000000509, TCRN0000000510, TCRN0000000511 and
TCRN0000000513 (Sigma-Aldrich; MISSION TCR1 library),
respectively, together with the aforementioned packaging con-
structs. LV.sh.eGFP and LV.sh.hif1a encode shRNAs directed
against, respectively, eGFP and hif1a (4 nucleotide mismatches with
that of the human homologue) transcripts. Cells transduced with
LV.sh.eGFP or LV.sh.hif1a served, together with mock-infected
myoblasts and myoblasts
GS.Luc, as negative controls in p38a
expression knock-down experiments.
Physical particle titers were determined using the RETRO-
TEK HIV-1 p24 Antigen ELISA kit (ZeptoMetrix) following the
instructions provided by the manufacturer. Titers of lentivirus
vector stocks expressed in terms of TU/ml were derived by using a
conversion factor of 10 TU per pg of p24 protein.
Cell transductions
Human myoblasts and hMSCs were seeded at a density of
2610
5 and 3610
4 cells per well of 24-well plates (Greiner Bio-
One), respectively, and were exposed overnight (circa 20 hours) to
viral vectors in a humidified-air 10% CO2 atmosphere. Next, the
cell monolayers were rinsed multiple times with large volumes of
PBS after which fresh medium was added. Mock infections were
carried out in parallel cultures by using exclusively the respective
cell type’s culture medium.
Co-culture establishment and maintenance
Co-cultures containing 10
5 or 2610
5 cells were established in
wells of 24-well plates by mixing myoblasts
FLPe with myoblasts
GS.Luc
in the specified ratios After an incubation period of 48 to 72 hours
the growth medium waseithersubstituted bydifferentiation medium
or by fresh growth medium. Unless otherwise indicated, the
differentiation was allowed to proceed for 5 days after which the
cultures were processed for analysis.
Small-molecule drug inhibition of the p38 MAPK
pathway in human myoblast cultures
Myoblasts
FLPe and myoblasts
GS.Luc were seeded in a 1:1 ratio at
a final total density of 2610
5 cells per well of 24-well plates. After 3
days of co-culture, the growth medium was replaced with
differentiation medium, differentiation medium containing 0.1,
0.5 or 2.5 mM of 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-
1H-imidazol-5-yl]pyridine (SB 203580; Promega) or differentia-
tion medium containing the same final concentration of SB
203580’s vehicle dimethyl sulphoxide (Hybri-Max; Sigma-Aldrich)
as the co-cultures incubated with 2.5 mM of the p38a/b inhibitor.
The different types of media were replenished every 24 hours.
Generation of cell lysates and luciferase measurements 3 days after
the addition of the various types of differentiation media were
carried out as described under ‘‘Luciferase assay’’.
Western blot analysis of shRNA-mediated knock-down of
p38a gene expression
The various shRNA-encoding polyclonal lines were established
by exposing myoblasts and myoblasts
GS.Luc for 24 hours to clarified
supernatants of LV.sh.eGFP, LV.sh.hif1a, LV.sh.p38a.33,
LV.sh.p38a.34, LV.sh.p38a.35 and LV.sh.p38a.36 producer cells.
Subsequently, these polyclonal lines were sub-cultured in the
presence of 0.5 mg/ml of puromycin. Control cells corresponding to
parental myoblasts and myoblasts
GS.Luc did not survive this drug
selection regimen.
Monolayers of myoblasts and myoblasts
GS.Luc either mock-
transduced or stably transduced with the shRNA-encoding
sequences targeting eGFP, hif1a and p38a transcripts (2610
5 cells)
were rinsed with ice-cold PBS and dissolved in 100 ml of ice-cold
lysis buffer composed of 20 mM Tris-HCl (pH 7.6), 150 mM
NaCl, 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium
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of protease inhibitors (Complete Mini, Roche Applied Science).
Next, the lysates were spun for 8 min at 4uC at 20,8006g. Prior to
sample loading, the total protein concentration in the various cell
lysates was determined by using the BCA Protein Assay Kit
(Thermo Fisher Scientific) and a bovine serum albumin standard
curve. Instructions corresponding to the microplate procedure, as
provided by the manufacturer, were followed except for the use of
3 instead of 25 ml of cell lysate. Also, the absorption measurements
were performed at 545 instead of 562 nm in a Wallace 1420
VICTOR 3 multilabel plate reader (PerkinElmer). Next, equal
protein amounts were subjected to electrophoresis through an
SDS-12% polyacrylamide gel after which they were transferred
onto an Immobilon-P membrane (Millipore) by electroblotting
overnight. After incubation with blocking solution (10 mM Tris-
HCl [pH 8.0], 150 mM NaCl and 0.05% Tween-20 [TBST])
supplemented with 10% (w/v) non-fat dry milk powder (Elk,
Campina), the membranes were incubated overnight at 4uC with
the rabbit anti-human p38a affinity-purified IgG antibody
AF8691 (R&D systems) diluted 1:3000 in blocking solution.
Subsequently, the membranes were washed 4 times with TBST at
room temperature and subjected to a 3-hour incubation with
horseradish peroxidase-conjugated goat-anti-rabbit IgG secondary
antibody (SC-2009; Santa Cruz Biotechnology) diluted 1:5000 in
blocking solution. Detection of a/b-tubulin proteins by using a
rabbit anti-human a/b-tubulin affinity-purified IgG antibody
(2148; Cell Signaling Technology) at a dilution of 1:5000,
provided for loading controls. Finally, the membranes were rinsed
and processed for protein detection by chemiluminescence as
described elsewhere [22].
Effect of shRNA-mediated knock-down of p38a gene
expression on human muscle cell fusion
Myoblasts, myoblasts
sh.hif1a, myoblasts
sh.p38a.33 and myo-
blasts
sh.p38a.36 were seeded at a density of 1.5610
5 cells in wells of
24-well plates. After an overnight incubation period, the cells were
exposed for circa 16 hours to either LV.FLPe.PurR (15 TU/cell) or
LV.GS.Luc (30 TU/cell). After being expanded via sub-culturing,
the resulting FLPe-encoding cells were mixed at a 1:1 ratio with
their respective GS.Luc-containing counterparts (i.e. 10
5 myo-
blasts
sh.p38a.36FLPe were mixed with 10
5 myoblasts
sh.p38a.36GS.Luc
and so forth). Following 3 days in growth medium, the four different
types of co-cultures were incubated in differentiation medium for 4
additional days, after which, reporter gene expression was
determined as specified below.
Luciferase assay
Cell monolayers in wells of 24-well plates were washed with 1 ml
of PBS and were lysed by incubation for 20 minutes in 200 ml of ice-
cold lysis buffer consisting of 25 mM Tris-phosphate (pH 7.8),
2 mM dithiothreitol, 2 mM EDTA (pH 8.0), 10% glycerol and 1%
Triton X-100. During the incubation period with the lysis buffer,
the plates were swirled approximately every 5 minutes to
homogenize the constituents present in the wells. Subsequently,
the recovered cell lysates were spun at 14,000 rpm for 3 minutes
at 4uC in a microcentrifuge (Eppendorf 5417R). The resulting
supernatants were stored at 220uC until analysis. The luciferase
activity present in one-tenth of each supernatant was measured with
the aid of a Wallace 1420 VICTOR 3 multilabel plate reader
loaded with luciferase assay substrate (Promega) reconstituted in
luciferase assay buffer (Promega) as specified by the supplier.
Fluorescence microscopy
The equipment and methods used for the light microscopy
analyses have been described before [22,32–34].
Flow cytometry
The flow cytometry instrument and procedures have been
specified elsewhere [22,34].
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